You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
AFC reported third-quarter net investment income of $0.16 per weighted average share and NAV of $8.55. It repurchased shares below NAV, purchased $19 million of senior notes and expects to commit to a $43 million healthcare facility.
Advanced Flower Capital Inc. reported third-quarter GAAP net investment income of $3.5 million, or $0.16 per weighted average share, for the quarter ended September 30, 2026. NAV per share was $8.55, compared with $8.25 as of June 30, 2026.
Advanced Flower Capital Inc. converted to a BDC effective January 1, 2026. For the nine months ended September 30, 2026, net investment income was $11,843,850 and net assets increased by $23,187,643; nonaccrual investments represented 36.0% of amortized cost.
Advanced Flower Capital Inc. entered the Tenth Amendment on September 25, 2026, temporarily increasing aggregate revolver commitments to $130 million through quarterly increases of up to $50 million, reverting to $80 million, while revising advance-rate conditions and loan fees.
Useful current figures from the complete screener profile.
* Q4 derived as the full year minus Q1 to Q3.
TL;DR. AFC reported Q2 2026 net investment income of $0.15 per share with NAV per share rising to $8.25 from $7.90, while total investment income declined sequentially to $8.7 million from $9.8 million due to non-recurring exit fees in the prior quarter, and legacy cannabis loan workouts continued with a binding $12.5 million Debbie asset sale.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Illustrative technical + ownership context — a signal mix, not investment advice.
| Metric | Latest | Period | YoY |
|---|---|---|---|
| Asset coverage | 190% | Q2 FY2026 | — |
| Debt-to-equity | 1.1 | Q2 FY2026 | — |
| Gross investment fundings | $17.2M | Q2 FY2026 | — |
| Investment portfolio at fair value | $289.8M | Q2 FY2026 | — |
| Net debt-to-equity | 0.53 | Q2 FY2026 | — |
| Net investment fundings | $8M | Q2 FY2026 | — |
| Number of portfolio companies | 17 | Q2 FY2026 | — |
| Share repurchase program authorization | $5M | Q2 FY2026 | — |
| Shares repurchased | 839,406 | Q2 FY2026 | — |
| Total available liquidity | $70M | Q2 FY2026 | — |
| Weighted average interest rate on debt outstanding | 6.3% | Q2 FY2026 | — |
| Weighted average share repurchase price | $3.29 | Q2 FY2026 | — |
| Weighted average yield on income producing debt investments | 13.2% | Q2 FY2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
AFCG
this stock
Advanced Flower Capital Inc.
|
$74.38M | +16.5% | -46.2% | 3.2 | 2.7% |
|
BLK
BlackRock, Inc.
|
$198.15B | +14.3% | +16.2% | 27.9 | 1.3% |
|
BN
BROOKFIELD Corp
|
$91.46B | -10.7% | — | — | 1.0% |
|
BX
Blackstone Inc.
|
$90.28B | -22.0% | +9.2% | 26.8 | 2.6% |
|
KKR
KKR & Co. Inc.
|
$87.47B | -23.1% | -11.0% | — | 1.6% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
Advanced Flower Capital Inc. converted to a BDC effective January 1, 2026. For the nine months ended September 30, 2026, net investment income was $11,843,850 and net assets increased by $23,187,643; nonaccrual investments represented 36.0% of amortized cost.
View| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| AFCG | +4.7% | +7.4% | -8.8% | +10.3% | +16.5% |
| SPY | +2.6% | -1.2% | +0.5% | -0.2% | +10.6% |
| vs SPY | +2.1% | +8.6% | -9.3% | +10.5% | +5.9% |
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.
